New Rochelle, NY, February 21, 2013-By targeting the specific mutation that causes the hereditary neuromuscular disease myotonic dystrophy, it is possible to neutralize the mutant RNA toxicity and minimize or even eliminate the disabling symptoms of the disease.
via New Rochelle Newswire http://www.eurekalert.org/pub_releases/2013-02/mali-dds022113.php
via New Rochelle Newswire http://www.eurekalert.org/pub_releases/2013-02/mali-dds022113.php
No comments:
Post a Comment